Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of VCT220 for obesity/overweight in a Chinese population has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• VCT220

Snippet

Sponsor: Vincentage Pharma Co., Ltd | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED